PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
-11.86%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$419M
AUM Growth
+$419M
(+106%)
Cap. Flow
-$106M
Cap. Flow
% of AUM
-25.3%
Top 10 Holdings %
Top 10 Hldgs %
94.43%
Holding
81
New
5
Increased
3
Reduced
13
Closed
15
Top Buys
| 1 |
Alphatec Holdings
ATEC
|
$4.61M |
| 2 |
Evolent Health
EVH
|
$2.13M |
| 3 |
DaVita
DVA
|
$1.31M |
| 4 |
Chewy
CHWY
|
$969K |
| 5 |
DexCom
DXCM
|
$963K |
Top Sells
| 1 |
Glaukos
GKOS
|
$23.8M |
| 2 |
Natera
NTRA
|
$9.72M |
| 3 |
Kenvue
KVUE
|
$9.06M |
| 4 |
Quanterix
QTRX
|
$8.47M |
| 5 |
Mettler-Toledo International
MTD
|
$7.2M |
Sector Composition
| 1 | Healthcare | 99.45% |
| 2 | Consumer Discretionary | 0.23% |
| 3 | Consumer Staples | 0% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDVL
1
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $328M | 50% | 58,070 | – | – |
|
|
2
Quanterix
QTRX
$211M
| $17.8M | 2.72% | 651,332 -309,909 | -32% | -$8.47M |
|
3
Establishment Labs
ESTA
$1.2B
| $10.8M | 1.65% | 417,994 -123,229 | -23% | -$3.19M |
|
4
Lyra Therapeutics
LYRA
$11.5M
| $7.41M | 1.13% | 1,413,242 | – | – |
|
5
LivaNova
LIVN
$3.08B
| $6.73M | 1.03% | 130,000 -131,148 | -50% | -$6.79M |
|
6
Pulmonx
LUNG
$69.7M
| $6.09M | 0.93% | 477,398 -248,900 | -34% | -$3.17M |
|
|
7
Natera
NTRA
$23.1B
| $5.83M | 0.89% | 93,000 -155,131 | -63% | -$9.72M |
|
8
Avita Medical
RCEL
$117M
| $4.95M | 0.76% | 361,096 -119,547 | -25% | -$1.64M |
|
|
9
Alphatec Holdings
ATEC
$2.35B
| $4.61M | 0.7% | +305,000 | New | +$4.61M |
|
|
CUTR
10
DELISTED
Cutera, Inc.
CUTR
| $3.77M | 0.58% | 1,070,494 -179,639 | -14% | -$633K |
|
11
Elanco Animal Health
ELAN
$9.12B
| $3.43M | 0.52% | 230,000 -215,914 | -48% | -$3.22M |
|
|
12
DexCom
DXCM
$29.5B
| $3.25M | 0.5% | 26,157 +7,757 | +42% | +$963K |
|
13
Insulet
PODD
$23.9B
| $2.71M | 0.41% | 12,500 +2,500 | +25% | +$542K |
|
|
14
Evolent Health
EVH
$1.12B
| $2.13M | 0.33% | +64,573 | New | +$2.13M |
|
15
Inspire Medical Systems
INSP
$2.77B
| $2.03M | 0.31% | 10,000 -30,487 | -75% | -$6.2M |
|
|
IMDX
16
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $1.47M | 0.22% | 586,930 -71,191 | -11% | -$178K |
|
17
SOPHiA GENETICS
SOPH
$234M
| $1.34M | 0.2% | 284,724 | – | – |
|
|
18
DaVita
DVA
$9.85B
| $1.31M | 0.2% | +12,500 | New | +$1.31M |
|
19
InspireMD
NSPR
$102M
| $1.27M | 0.19% | 450,517 +94,326 | +26% | +$265K |
|
20
AdvisorShares Pure US Cannabis ETF
MSOS
$986M
| $1.25M | 0.19% | 178,309 -150,000 | -46% | -$1.05M |
|
|
21
Chewy
CHWY
$16.9B
| $969K | 0.15% | +41,000 | New | +$969K |
|
22
Myriad Genetics
MYGN
$593M
| $957K | 0.15% | +50,000 | New | +$957K |
|
|
NYXH
23
Nyxoah
NYXH
$234M
| $523K | 0.08% | 111,467 | – | – |
|
24
Guardant Health
GH
$8.41B
| $406K | 0.06% | 15,000 -7,943 | -35% | -$215K |
|
25
Apyx Medical
APYX
$75.3M
| $210K | 0.03% | 80,000 -756,990 | -90% | -$1.98M |
|